A carregar...

Negative Effect of Immediate Sunitinib Interruption on Survival in Patients With Metastatic Renal Cell Carcinoma

Background: Treatment modification due to adverse events reduces the dose intensity in cancer treatment. The prognostic impact of sunitinib treatment interruption within the initial period of therapy for metastatic renal cell carcinoma (mRCC) remains unknown. Patients and Methods: We retrospectively...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: ISHIYAMA, RYO, ISHIHARA, HIROKI, KONDO, TSUNENORI, TAKAGI, TOSHIO, YOSHIDA, KAZUHIKO, IIZUKA, JUNPEI, KOBAYASHI, HIROHITO, OKUMI, MASAYOSHI, ISHIDA, HIDEKI, TANABE, KAZUNARI
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899126/
https://ncbi.nlm.nih.gov/pubmed/31662551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11717
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!